AudioScholar Urology Weekly

AudioScholar
  • 0.0 (0)
  • Medicine
  • Weekly

Urology — a weekly podcast briefing of the most significant peer-reviewed urology literature, synthesized from PubMed and delivered as ~10-minute audio. For practicing physicians. Generated by AudioScholar at audioscholar.cc.

  1. 2d ago

    This Week in Urology — Oct 30, 2026

    Editor's Pick: Durvalumab, Tremelimumab, and Enfortumab Vedotin in Muscle-Invasive Bladder Cancer (New England Journal of Medicine, 2026) This AudioScholar briefing is generated by artificial intelligence for healthcare professionals and trainees. It is not medical advice. Welcome to This Week in Urology. This week we're covering 10 notable papers spanning perioperative immunotherapy in bladder and kidney cancer, decision-making and recovery in prostate cancer, and the surgical craft of benign prostatic and penile canc… This week's papers: 1. Durvalumab, Tremelimumab, and Enfortumab Vedotin in Muscle-Invasive Bladder Cancer. — New England Journal of Medicine 2026 2. Neoadjuvant nivolumab with or without visugromab in muscle-invasive bladder cancer: the phase 2a GDFATHER-NEO trial. — Nature Medicine 2026 3. Advances in the management of renal cell carcinoma. — BMJ 2026 4. A Trial-Level Benefit-Toxicity Mapping Framework for Adjuvant Therapy in Renal Cell Carcinoma: A Focused Review. — International Journal of Urology 2026 5. Management of Patients with High-risk Localised, Locally Advanced, and Biochemically Recurrent Prostate Cancer: Report from the 2026 Advanced Prostate Cancer C… — European Urology 2026 6. A Randomized Trial of Multimodal Prehabilitation Before Robotic-Assisted Radical Prostatectomy to Improve Postoperative Quality of Life and Functional Outcomes. — The Journal of Urology 2026 7. Bipolar Enucleation of the Prostate Versus Transurethral Resection of the Prostate: A Prospective Randomized Controlled Noninferiority Trial. — European Urology Focus 2026 8. Initiation of Medical Therapy for Storage Lower Urinary Tract Symptoms After Benign Prostatic Hyperplasia Surgery. — The Journal of Urology 2026 9. Surgery in Motion: Different Surgical Techniques for Inguinal Lymph Node Dissection in Penile Cancer. — European Urology 2026 10. Dynamic Sentinel Lymph Node Biopsy (DSNB) in Penile Cancer: A Practical Guide for Clinical Implementation. — European Urology Focus 2026 Listen at https://audioscholar.cc/episode/ukzyyb4v9h

  2. Oct 23

    This Week in Urology — Oct 23, 2026

    Editor's Pick: Validation of Cxbladder Triage Plus in Australian patients with haematuria: the AUSSIE study (BJU International, 2026) This AudioScholar briefing is generated by artificial intelligence for healthcare professionals and trainees. It is not medical advice. Welcome to This Week in Urology. This week we're covering 10 notable papers spanning stone and surgical technique, biomarker-driven risk stratification in prostate and bladder cancer, and real-world systemic therapy for urothelial carcinoma. This week's papers: 1. Transient apnoea for motion control during flexible ureteroscopic lithotripsy: a randomised trial. — BJU International 2026 2. Does bespoke metabolic investigation reduce urinary stone recurrence? A narrative review. — BJU International 2026 3. Early apical release versus conventional (non-early apical release) holmium laser enucleation of the prostate: a systematic review and meta-analysis of postope… — Prostate Cancer and Prostatic Diseases 2026 4. Intraoperative performance errors predict patient outcomes in robot-assisted radical prostatectomy. — BJU International 2026 5. Circulating Immune and Cancer Driver Gene Biomarkers Precede Prostate Cancer Diagnosis by over 10 yr. — European Urology 2026 6. Risk-stratified Prostate Cancer Screening in 2026: Blood- and Urine-based Biomarkers. — European Urology Focus 2026 7. Development and Validation of the JIKEI-YAYOI Score for Predicting Castration Resistance in Metastatic Castration-Sensitive Prostate Cancer Treated With ARSI-B… — International Journal of Urology 2026 8. Validation of Cxbladder Triage Plus in Australian patients with haematuria: the AUSSIE study. — BJU International 2026 9. Oncological Outcomes and Safety Profiles of Adjuvant Nivolumab in Muscle-Invasive Urothelial Carcinoma. — International Journal of Urology 2026 10. Changes in Treatment Patterns and Survival Outcomes Across Therapeutic Eras in Metastatic Urothelial Carcinoma: A Multicenter Real-World Study. — International Journal of Urology 2026 Listen at https://audioscholar.cc/episode/fdv3hqmmty

  3. Oct 16

    This Week in Urology — Oct 16, 2026

    Editor's Pick: 177Lu-Prostate-specific Membrane Antigen Prior to Stereotactic Ablative Radiotherapy in Oligorecurrent Prostate Cancer: Secondary and Exploratory End Point Results from the Randomized Phase 2 LUNAR Trial (European Urology, 2026) This AudioScholar briefing is generated by artificial intelligence for healthcare professionals and trainees. It is not medical advice. Welcome to This Week in Urology. This week we're covering 10 notable papers spanning advanced and localized prostate cancer, urothelial cancer staging and bladder-sparing therapy, and diagnostic and device innovations in testis and stone care. This week's papers: 1. 177Lu-Prostate-specific Membrane Antigen Prior to Stereotactic Ablative Radiotherapy in Oligorecurrent Prostate Cancer: Secondary and Exploratory End Point Res… — European Urology 2026 2. Metabolic and oncological effects of metformin added to ADT in prostate cancer: systematic review and meta-analysis including STAMPEDE. — Prostate Cancer and Prostatic Diseases 2026 3. Perilesional biopsy in - systematic out? Comparative analysis of targeted, perilesional and systematic core yield by needle tracking with robotic-assisted tran… — Urology 2026 4. EQUIPOISE: EQUivalence In Prostate cancer treatment: surgery Or radiotherapy? An Intention-to-treat Survival analysis from real-world Evidence. — World Journal of Urology 2026 5. Transurethral ultrasound ablation (TULSA) for prostate cancer: a systematic review and meta-analysis. — BJU International 2026 6. Anatomical Mapping of Lymphatic Leakage Leading to Symptomatic Lymphoceles Formation After Pelvic Lymph Node Dissection for Prostate Cancer. — The Journal of Urology 2026 7. Contemporary Oncological and Patient-reported Outcomes of Intravesical Gemcitabine/Docetaxel in BCG-unresponsive Non-muscle-invasive Bladder Cancer: A Multi-in… — European Urology Focus 2026 8. [18F]fluorodeoxyglucose PET/CT refines staging and treatment selection in high-risk upper tract urothelial carcinoma. — BJU International 2026 9. Comparative accuracy of imaging modalities for differentiating malignant small testicular masses. — BJU International 2026 10. A novel ureteric stent coating reduces encrustation and improves tolerability in a randomised trial. — BJU International 2026 Listen at https://audioscholar.cc/episode/d3xht8h22j

  4. Oct 9

    This Week in Urology — Oct 9, 2026

    Editor's Pick: Major Adverse Cardiovascular Events in Men with High-risk Localized or Metastatic Prostate Cancer Starting Long-term Hormone Therapy in the STAMPEDE Trial (European Urology, 2026) This AudioScholar briefing is generated by artificial intelligence for healthcare professionals and trainees. It is not medical advice. Welcome to This Week in Urology. This week we're covering 10 notable papers spanning prostate cancer imaging and risk stratification, the safety and biology of hormonal intensification, and new tools and endpoints in bladder cancer, with a closing lo… This week's papers: 1. Diagnostic Value of Prostate-specific Membrane Antigen Positron Emission Tomography / Magnetic Resonance Imaging in Selected Men with Equivocal Prostate Imagin… — The Journal of Urology 2026 2. Gleason pattern 4 length and active surveillance eligibility in Grade Group 2-4 prostate cancer. — BJU International 2026 3. PSMA-PET/CT-guided Intensification of Radiation Therapy for Prostate Cancer (PSMAgRT): 5-yr Analysis of a Phase 2 Randomized Controlled Trial. — European Urology 2026 4. Major Adverse Cardiovascular Events in Men with High-risk Localized or Metastatic Prostate Cancer Starting Long-term Hormone Therapy in the STAMPEDE Trial. — European Urology 2026 5. Testosterone breakthrough and outcomes during intensified therapy in metastatic hormone-sensitive prostate cancer: the ARASENS and LATITUDE trials. — BJU International 2026 6. Urine cell-free RNA for bladder cancer detection and treatment response prediction. — Nature Medicine 2026 7. Accumulating Evidence Supports NECTIN4 as a Predictive Biomarker for Enfortumab Vedotin: The Compartment Still Matters. — European Urology 2026 8. Surrogacy of intermediate clinical endpoints for overall survival in BCG-naïve high-risk non-muscle-invasive bladder cancer. — World Journal of Urology 2026 9. Post-chemotherapy retroperitoneal lymph node dissection following first-line treatment in patients with advanced pure seminoma of the testis. — The Journal of Urology 2026 10. Lymphocele After Radical Prostatectomy: A Systematic Review of Risk Factors and Quantitative Synthesis Preventive Strategies. — World Journal of Urology 2026 Listen at https://audioscholar.cc/episode/59c94ktw4e

  5. Oct 2

    This Week in Urology — Oct 2, 2026

    Editor's Pick: The PSA test for prostate cancer screening: an abridged Cochrane review (BJU International, 2026) This AudioScholar briefing is generated by artificial intelligence for healthcare professionals and trainees. It is not medical advice. Welcome to This Week in Urology. This week we're covering 10 notable papers spanning prostate cancer screening and surgical quality, bladder and kidney cancer treatment, and a cluster of endourology studies on access, positioning and stone-free predi… This week's papers: 1. The PSA test for prostate cancer screening: an abridged Cochrane review. — BJU International 2026 2. Prostate Cancer Screening and Likelihood of Benefit in Veterans Affairs and Fee-for-Service Medicare. — JAMA Internal Medicine 2026 3. A Phase I Clinical Trial of Chemoimmunotherapy with Alternating Intravesical Gemcitabine and Bacillus Calmette-Guérin (GemBCG) for BCG-Exposed High-Grade Non-M… — The Journal of Urology 2026 4. The effect of time to nephrectomy on cancer-specific mortality in pathological T stage (pT)1b-2 renal cancer. — BJU International 2026 5. Oncological and continence outcomes after nerve-sparing robot-assisted radical prostatectomy in selected STAMPEDE-defined high-risk prostate cancer. — BJU International 2026 6. Aetiology of positive surgical margins in robotic assisted radical prostatectomy: a pathway approach. — World Journal of Urology 2026 7. First-in-clinical Evaluation of Dual Contrast-enhanced Ultrasound-guided PCNL: A Multicenter Randomized Trial Versus Fluoroscopy. — European Urology Focus 2026 8. Risk Factors for Primary Retrograde Ureteral Access Failure During Ureteroscopy-A Systematic Review and Meta-Analysis by the YAU and EAU Section of Endourology. — Journal of Endourology 2026 9. Intraoperative positioning strategies to improve stone-free outcomes during retrograde intrarenal surgery: a systematic review and meta-analysis. — World Journal of Urology 2026 10. Development and internal validation of a preoperative score for predicting postoperative residual stone after mini-percutaneous nephrolithotomy. — World Journal of Urology 2026 Listen at https://audioscholar.cc/episode/p4kpfjt7vk

  6. Sep 25

    This Week in Urology — Sep 25, 2026

    Editor's Pick: Multicenter Randomized Controlled Trial Comparing Pulse-Modulated Holmium:YAG Laser and Thulium Fiber Laser in Retrograde Intrarenal Surgery for Dusting Kidney Stones (The Journal of Urology, 2026) This AudioScholar briefing is generated by artificial intelligence for healthcare professionals and trainees. It is not medical advice. Welcome to This Week in Urology. This week we're covering 10 notable papers spanning prostate cancer detection and risk stratification, endourology and stone treatment, and reconstructive and functional urology, with a biomarker story from advanced u… This week's papers: 1. MUSegNet: Automated detection of clinically significant prostate cancer on micro-ultrasound. — Prostate Cancer and Prostatic Diseases 2026 2. PHI for adverse pathology and PHI density for upgrading: two complementary predictors in localized prostate cancer. — Prostate Cancer and Prostatic Diseases 2026 3. How to Biopsy in Prostate Cancer Screening and Early Detection and Who Needs Antibiotics. — European Urology Focus 2026 4. Cancer-specific mortality in high-risk or very high-risk prostate cancer patients treated with cryotherapy vs. external beam radiation therapy. — World Journal of Urology 2026 5. Pretreatment Tumor NECTIN4 RNA Expression Is Associated with First-line Enfortumab Vedotin Plus Pembrolizumab Efficacy in Metastatic Urothelial Cancer. — European Urology 2026 6. Multicenter Randomized Controlled Trial Comparing Pulse-Modulated Holmium:YAG Laser and Thulium Fiber Laser in Retrograde Intrarenal Surgery for Dusting Kidney… — The Journal of Urology 2026 7. Rethinking high-frequency lithotripsy: a review by EAU endourology group. — World Journal of Urology 2026 8. Navigating the irradiated ureter: multi-institutional outcomes of robotic ureteral reconstruction for radiation-induced strictures. — World Journal of Urology 2026 9. Surgical Treatment of Pelvic Organ Prolapse and Overactive Bladder: A Systematic Review and Meta-Analysis. — Neurourology and Urodynamics 2026 10. Predictors of early surgical treatment after a first episode of acute urinary retention due to benign prostatic obstruction: a single-center retrospective coho… — World Journal of Urology 2026 Listen at https://audioscholar.cc/episode/5rce9mv4fc

  7. Sep 18

    This Week in Urology — Sep 18, 2026

    Editor's Pick: Bladder Cancer Incidence in Patients with Microhematuria at the Veterans Health Administration (The Journal of Urology, 2026) Welcome to This Week in Urology. This week we're covering 10 notable papers spanning stone disease and lithotripsy technology, prostate cancer screening and diagnosis, and a cluster of surgical and functional urology studies that ask whether newer te… This week's papers: 1. Prospective randomised double-blind trial: holmium laser lithotripsy with vs without Moses™ 2.0. — BJU International 2026 2. Potassium Citrate vs Thiazides for Empiric Stone Prevention: A Propensity-Matched Analysis. — Urology 2026 3. Prostate Cancer Screening: The Population Benefit Outweighs the Harm (Pro). — European Urology Focus 2026 4. Detection of Clinically-Significant Prostate Cancer on Systematic Biopsy in Patients with a PI-RADS 3-5 Lesion on MRI: Results from a Large Institutional Serie… — Urology 2026 5. Bladder Cancer Incidence in Patients with Microhematuria at the Veterans Health Administration. — The Journal of Urology 2026 6. Efficacy and safety of thulium fiber laser versus conventional holmium:YAG laser in anatomical endoscopic enucleation of the prostate: a systematic review and… — World Journal of Urology 2026 7. Transabdominal lumbar approach (TALA) versus retroperitoneal approach for robot-assisted renal surgery: a prospective randomised controlled trial. — World Journal of Urology 2026 8. Randomized Trial of Percutaneous Versus Transcutaneous Tibial Nerve Stimulation in The Treatment of Refractory Overactive Bladder: Results From The TRANSPER Tr… — Neurourology and Urodynamics 2026 9. Side-specific lower detrusor apron-sparing robot-assisted radical prostatectomy: functional and oncological outcomes. — World Journal of Urology 2026 10. Comparison of ultrasonic lithotripsy with Ho:YAG laser lithotripsy during percutaneous nephrolithotomy for 20-40 mm low-hardness renal calculi: a propensity sc… — World Journal of Urology 2026 Listen at https://audioscholar.cc/episode/uymbzqem3f

  8. Sep 11

    This Week in Urology — Sep 11, 2026

    Editor's Pick: Screening for Asymptomatic Bacteriuria Before Cystoscopy: A Systematic Review and Meta-analysis (European Urology Focus, 2026) Welcome to This Week in Urology. This week we're covering 10 notable papers spanning advanced prostate cancer systemic therapy and molecular imaging, the surgical management of bladder outflow obstruction and stone disease, and a set of studies that… This week's papers: 1. Impact of Treatment Intensification with Abiraterone on Fracture-related Hospitalisation in Newly Diagnosed Prostate Cancer: A Secondary Analysis of Two Random… — European Urology 2026 2. PSMA-PET Tumor Volume Stratifies Nonmetastatic Castration-resistant Prostate Cancer. — European Urology Focus 2026 3. Blue Laser Vaporization for Benign Prostatic Hyperplasia: A Prospective Cohort Study on Efficacy and Preservation of Ejaculation. — European Urology Focus 2026 4. Prostate surgery outcomes in patients presenting with and without a urethral catheter: a long-term comparative study. — World Journal of Urology 2026 5. Single-port robotic prostatectomy is associated with higher same-day discharge and reduced length of stay: a NSQIP analysis. — World Journal of Urology 2026 6. Suction-assisted ureteroscopy compared with traditional ureteroscopy for renal stones ≤ 2 cm: a systematic review, Bayesian network meta-analysis and meta-regr… — World Journal of Urology 2026 7. The effect of prestenting on the success rates of endourological stone surgery in children. — World Journal of Urology 2026 8. Perioperative Management of Direct Oral Anticoagulants in Urological Surgery: The Prospective PAUSE-URO Study. — European Urology Focus 2026 9. Screening for Asymptomatic Bacteriuria Before Cystoscopy: A Systematic Review and Meta-analysis. — European Urology Focus 2026 10. Contemporary Trends in Primary Retroperitoneal Lymph Node Dissection in Nonseminomatous Germ Cell Tumors. — European Urology Focus 2026 Listen at https://audioscholar.cc/episode/kr8y777s3c

See All (22)

About

Urology — a weekly podcast briefing of the most significant peer-reviewed urology literature, synthesized from PubMed and delivered as ~10-minute audio. For practicing physicians. Generated by AudioScholar at audioscholar.cc.

Information